Urokinase Plasminogen Activator System
- 1 October 2003
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Orthopaedics and Related Research
- Vol. 415, S46-S58
- https://doi.org/10.1097/01.blo0000093845.72468.bd
Abstract
No abstract availableThis publication has 75 references indexed in Scilit:
- Syk, a Protein-tyrosine Kinase, Suppresses the Cell Motility and Nuclear Factor κB-mediated Secretion of Urokinase Type Plasminogen Activator by Inhibiting the Phosphatidylinositol 3′-Kinase Activity in Breast Cancer CellsPublished by Elsevier BV ,2003
- Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cellsOncogene, 2003
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Inhibition of the Interaction of Urokinase-Type Plasminogen Activator (uPA) with Its Receptor (uPAR) by Synthetic PeptidesBiological Chemistry, 1997
- Requirement of Receptor-bound Urokinase-type Plasminogen Activator for Integrin αvβ5-directed Cell MigrationJournal of Biological Chemistry, 1996
- Inhibition of metastasis of lewis lung carcinoma by a synthetic peptide within growth factor‐like domain of urokinase in the experimental and spontaneous metastasis modelInternational Journal of Cancer, 1994
- Effective activation of the proenzyme form of the urokinase‐type plasminogen activator (pro‐uPA) by the cysteine protease cathepsin LFEBS Letters, 1992
- Protein Structure and Membrane Anchorage of the Cellular Receptor for Urokinase-Type Plasminogen ActivatorSeminars in Thrombosis and Hemostasis, 1991
- UROKINASE-TYPE PLASMINOGEN ACTIVATOR ANTIGEN AND EARLY RELAPSE IN BREAST CANCERThe Lancet, 1989
- Growth stimulation of human epidermal cells by urokinase is restricted to the intact active enzymeJBIC Journal of Biological Inorganic Chemistry, 1989